Ahmed Bennis/X
Nov 27, 2025, 05:00
LAAO vs. Anticoagulants․ What Works Best in ESRD Patients with AF?
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared on X:
”Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease.
In propensity-matched cohorts of ESRD patients with AF, the composite outcome of stroke or SE, MB, and all-cause mortality was higher in those treated with apixaban or warfarin compared with those who underwent LAAO.”
Read more here.
Stay updated with Hemostasis Today.
-
Sep 2, 2026, 09:52Rick Matthews: Expanding Mechanical Thrombectomy to Coronary Arteries
-
Sep 2, 2026, 09:49Yara Dixon: Barriers and Facilitators to Blood Donation Across Diverse Populations
-
Sep 2, 2026, 09:29Ana Sachetto: Liver Injury and Tissue Factor-Driven Coagulation
-
Sep 2, 2026, 09:28Kavya Keerthana: A Potentially Important Advance in Polycythemia Vera
-
Sep 2, 2026, 09:26Mohammad Zuryan: Pre-Marital Genetic Screening for Thalassemia Prevention
-
Sep 2, 2026, 09:23Mohammed Salman: 9 Key Changes in the Fifth Universal Definition of Myocardial Infarction
-
Sep 2, 2026, 07:02Christoph B. Olivier: Rapid Platelet Inhibition in Acute Coronary Syndromes
-
Sep 2, 2026, 06:38Gene Therapy for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Sep 2, 2026, 06:32Sanjay Batra: Exploring What Lies Beyond Platelet Counts